In Medical News Today is an article on using melatonin for the treatment of ALS (Lou Gehrig’s disease). What the research team found was melatonin was a powerful antioxidant that helps to block and slow down enzymes that cause cell death.
The experiments found that a lack of melatonin and their receptors were connected with the progression of ALS.
The mice that were treated with melatonin lived longer and developed the symptoms slower than the non-treated mice.
This research holds great promise in the treatment of ALS.